No label defined (Q31848)

From lgbtDB
Revision as of 15:14, 14 November 2024 by Superraptor (talk | contribs) (‎Created a new Item)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
No description defined
  • Rationale and design of the Self-TI Study protocol: a cross-sectional human papillomavirus self-testing pilot study among transgender adults in England.
Language Label Description Also known as
English
No label defined
No description defined
  • Rationale and design of the Self-TI Study protocol: a cross-sectional human papillomavirus self-testing pilot study among transgender adults in England.

Statements

title
Rationale and design of the Self-TI Study protocol: a cross-sectional human papillomavirus self-testing pilot study among transgender adults in England. (English)
1 reference
stated in
PubMed
abstract
Persistent infection with high-risk human papillomavirus (HPV) is the causal agent of several cancers including cervical, anal and oropharyngeal cancer. (English)
source label
INTRODUCTION (English)
subsection NLM category
background section
series ordinal
1
copyright statement
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. (English)
publisher
BMJ
date copyrighted
2024
rights holder
Q31839
Stewart O'Callaghan
Q31841
Q31843
Q31844
Q31782
1 reference
stated in
PubMed
Transgender men and transmasculine non-binary (TMNB) people with a cervix are much less likely to undergo cervical cancer screening than cisgender women. (English)
source label
INTRODUCTION (English)
subsection NLM category
background section
series ordinal
2
copyright statement
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. (English)
publisher
BMJ
date copyrighted
2024
rights holder
Q31839
Stewart O'Callaghan
Q31841
Q31843
Q31844
Q31782
1 reference
stated in
PubMed
Transgender women and transfeminine non-binary (TWNB) people assigned male at birth may be at increased risk of HPV. (English)
source label
INTRODUCTION (English)
subsection NLM category
background section
series ordinal
3
copyright statement
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. (English)
publisher
BMJ
date copyrighted
2024
rights holder
Q31839
Stewart O'Callaghan
Q31841
Q31843
Q31844
Q31782
1 reference
stated in
PubMed
Both TMNB and TWNB people face many barriers to HPV testing including medical mistrust due to stigma and discrimination. (English)
source label
INTRODUCTION (English)
subsection NLM category
background section
series ordinal
4
copyright statement
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. (English)
publisher
BMJ
date copyrighted
2024
rights holder
Q31839
Stewart O'Callaghan
Q31841
Q31843
Q31844
Q31782
1 reference
stated in
PubMed
The Self-TI Study (Self-TI) is a pilot study designed to measure acceptability and feasibility of HPV self-testing among transgender and non-binary people in England. (English)
source label
METHODS AND ANALYSIS (English)
subsection NLM category
methods section
series ordinal
5
copyright statement
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. (English)
publisher
BMJ
date copyrighted
2024
rights holder
Q31839
Stewart O'Callaghan
Q31841
Q31843
Q31844
Q31782
1 reference
stated in
PubMed
TMNB people aged 25-65 years, with at least 1 year of testosterone, and TWNB people, aged 18 years and over, are eligible to participate. (English)
source label
METHODS AND ANALYSIS (English)
subsection NLM category
methods section
series ordinal
6
copyright statement
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. (English)
publisher
BMJ
date copyrighted
2024
rights holder
Q31839
Stewart O'Callaghan
Q31841
Q31843
Q31844
Q31782
1 reference
stated in
PubMed
Participants self-collect up to four samples: an oral rinse, a first void urine sample, a vaginal swab (if applicable) and an anal swab. (English)
source label
METHODS AND ANALYSIS (English)
subsection NLM category
methods section
series ordinal
7
copyright statement
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. (English)
publisher
BMJ
date copyrighted
2024
rights holder
Q31839
Stewart O'Callaghan
Q31841
Q31843
Q31844
Q31782
1 reference
stated in
PubMed
TMNB participants are asked to have an additional clinician-collected cervical swab taken following their routine Cervical Screening Programme sample. (English)
source label
METHODS AND ANALYSIS (English)
subsection NLM category
methods section
series ordinal
8
copyright statement
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. (English)
publisher
BMJ
date copyrighted
2024
rights holder
Q31839
Stewart O'Callaghan
Q31841
Q31843
Q31844
Q31782
1 reference
stated in
PubMed
TWNB people are asked to take a self-collection kit to perform additional self-collection at home and mail the samples back to the clinic. (English)
source label
METHODS AND ANALYSIS (English)
subsection NLM category
methods section
series ordinal
9
copyright statement
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. (English)
publisher
BMJ
date copyrighted
2024
rights holder
Q31839
Stewart O'Callaghan
Q31841
Q31843
Q31844
Q31782
1 reference
stated in
PubMed
Acceptability is assessed by a self-administered online survey and feasibility is measured as the proportion of samples returned in the clinic and from home. (English)
source label
METHODS AND ANALYSIS (English)
subsection NLM category
methods section
series ordinal
10
copyright statement
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. (English)
publisher
BMJ
date copyrighted
2024
rights holder
Q31839
Stewart O'Callaghan
Q31841
Q31843
Q31844
Q31782
1 reference
stated in
PubMed
Self-TI received ethical approval from the Research Ethics Committee of Wales 4 and ethical review panel within the Division of Cancer Epidemiology and Genetics at the US National Cancer Institute. (English)
source label
ETHICS AND DISSEMINATION (English)
subsection NLM category
background section
series ordinal
11
copyright statement
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. (English)
publisher
BMJ
date copyrighted
2024
rights holder
Q31839
Stewart O'Callaghan
Q31841
Q31843
Q31844
Q31782
1 reference
stated in
PubMed
Self-TI was coproduced by members of the transgender and non-binary community, who served as authors, collaborators and members of the patient and public involvement (PPI) group. (English)
source label
ETHICS AND DISSEMINATION (English)
subsection NLM category
background section
series ordinal
12
copyright statement
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. (English)
publisher
BMJ
date copyrighted
2024
rights holder
Q31839
Stewart O'Callaghan
Q31841
Q31843
Q31844
Q31782
1 reference
stated in
PubMed
Results of this study will be shared with the community prior to being published in peer-reviewed journals and the PPI group will help to design the results dissemination strategy. (English)
source label
ETHICS AND DISSEMINATION (English)
subsection NLM category
background section
series ordinal
13
copyright statement
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. (English)
publisher
BMJ
date copyrighted
2024
rights holder
Q31839
Stewart O'Callaghan
Q31841
Q31843
Q31844
Q31782
1 reference
stated in
PubMed
The evidence generated from this pilot study could be used to inform a larger, international study of HPV self-testing in the transgender and non-binary community. (English)
source label
ETHICS AND DISSEMINATION (English)
subsection NLM category
background section
series ordinal
14
copyright statement
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. (English)
publisher
BMJ
date copyrighted
2024
rights holder
Q31839
Stewart O'Callaghan
Q31841
Q31843
Q31844
Q31782
1 reference
stated in
PubMed
NCT05883111. (English)
source label
TRIAL REGISTRATION NUMBER (English)
subsection NLM category
background section
series ordinal
15
copyright statement
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. (English)
publisher
BMJ
date copyrighted
2024
rights holder
Q31839
Stewart O'Callaghan
Q31841
Q31843
Q31844
Q31782
1 reference
stated in
PubMed
date published
4 July 2024
1 reference
stated in
PubMed
date issued
4 July 2024
1 reference
stated in
PubMed
volume
14
1 reference
stated in
PubMed
issue
7
1 reference
stated in
PubMed
MeSH subject
page(s)
e086099
1 reference
stated in
PubMed
page start
e086099
1 reference
stated in
PubMed
conflict-of-interest statement
Competing interests: AMB is a trustee of OUTpatients, of which SOC is the CEO. (English)
series ordinal
1
1 reference
stated in
PubMed
None of the other authors have any conflicts to declare. (English)
series ordinal
2
1 reference
stated in
PubMed
 
Retrieved from "https://lgbtdb.wikibase.cloud/w/index.php?title=Item:Q31848&oldid=189279"